SMAD4 mutations found in unselected HHT patients

Area of Science:

• Genetics
• Molecular Biology
• Medical Genetics

Background:

• Hereditary haemorrhagic telangiectasia (HHT) is an autosomal dominant vascular disorder.
• Mutations in endoglin (ENG) and activin receptor-like kinase 1 (ALK1) genes are common causes of HHT.
• SMAD4 mutations are associated with the combined juvenile polyposis (JP) and HHT (JP-HHT) syndrome.

Purpose of the Study:

• To investigate the prevalence of SMAD4 mutations in HHT patients without a prior JP diagnosis.
• To assess the clinical implications of identifying SMAD4 mutations in this HHT cohort.

Main Methods:

• Genetic analysis of 30 unrelated HHT patients negative for ENG and ALK1 mutations.
• DNA-based testing for mutations in the SMAD4 gene.

Main Results:

• SMAD4 mutations were identified in 10% (3/30) of the tested HHT patients.
• The identified SMAD4 mutations were consistent with those observed in JP-HHT syndrome.

Conclusions:

• SMAD4 mutation screening should be considered in HHT patients with negative ENG and ALK1 results.
• Patients with SMAD4 mutations require screening for JP-associated polyps due to increased gastrointestinal cancer risk.